UK scientists: Zavesca is expected to inhibit the novel coronavirus

Scientists from the Oxford Glycobiology Institute has found that Zavesca, an iminosugar drug that has been on the market for nearly 20 years, as well as two other iminosugar drug molecules in clinical 2A trials – testing on real patients – for the treatment of hepatitis B virus, dengue virus and influenza virus, were expected to inhibit the novel coronavirus.

Read more：

UK scientists: Zavesca is expected to inhibit the novel coronavirus